An interventional study of counseling intervention and screening colonoscopy in Colorectal Cancer and Precancerous Condition, sponsored by Harvard Medical School (HMS and HSDM). Completed at 2 sites in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2013-12-19.
Sponsored by Harvard Medical School (HMS and HSDM) · Not applicable and Interventional
RATIONALE: Receiving a reminder letter from their doctor may increase the frequency of colonoscopy in patients who have had a colorectal polyp removed.
PURPOSE: This randomized clinical trial is studying how well a reminder letter from their doctor improves the frequency of colonoscopy in patients who have had a colorectal polyp removed.
OBJECTIVES:
OUTLINE: This is a randomized, controlled, crossover study. Patients are stratified according to age (≤ 65 years of age vs > 65 years of age), gender, time elapsed since last colonoscopy, and primary care physician's (PCP) membership in Harvard Vanguard Medical Associates (yes vs no). Patients are randomized to 1 of 2 arms.
PROJECTED ACCRUAL: A total of 800 patients will be accrued for this study.
254 studies on the registry are indexed under Precancerous Conditions; 28 are open to participants now.
This study's planned enrollment of 800 is above the median of 60 across 163 interventional studies indexed under Precancerous Conditions.
Browse Precancerous Conditions studies →Harvard Medical School (HMS and HSDM) is the lead sponsor of 53 studies on the registry; 12 are open to participants now.
Counted across the registry records on this site, refreshed daily.
DISEASE CHARACTERISTICS:
Underwent prior colonoscopy with polypectomy at Brigham and Women's Hospital
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Successful completion of follow-up colonoscopy
Number of patients completing colonoscopy during the study period
This study is completed, as verified in Dec 2006. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Harvard Medical School (HMS and HSDM)